• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寡转移性前列腺腺癌患者中,是否需要对MDP摄取微弱的区域进行进一步评估?

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

作者信息

Sharma Anshul, Dwivedi Ankur

机构信息

Department of Nuclear Medicine, Homi Bhabha Cancer Hospital and Research Centre, Punjab, India.

Department of Radiodiagnosis, Homi Bhabha Cancer Hospital and Research Centre, Punjab, India.

出版信息

World J Nucl Med. 2022 Oct 28;22(1):40-42. doi: 10.1055/s-0042-1757281. eCollection 2023 Mar.

DOI:10.1055/s-0042-1757281
PMID:36923982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10010852/
Abstract

A 42-year-old male patient with high-risk prostate adenocarcinoma underwent baseline Tc-methylene diphosphonate skeletal scintigraphy, which revealed two skeletal metastases and an area of faint radiotracer uptake in the left femoral shaft. In view of oligo-metastatic nature of the disease in the bone scan and the young age of the patient, he was a candidate for metastases-directed treatment. Single photon emission computed tomography (SPECT)/CT was performed to further characterize this lesion. It was revealed to be a small soft tissue density lesion within the fatty bone marrow density, suggesting bone marrow involvement. A more sensitive evaluation of such areas with faint radiotracer uptake may be needed in high-risk prostate cancer patients where access to advanced modalities is limited. Their significance will also need reassessment as their detection will improve with technological advancements.

摘要

一名42岁的高危前列腺腺癌男性患者接受了基线锝-亚甲基二膦酸盐骨闪烁显像,结果显示有两处骨转移以及左股骨干处有一放射性示踪剂摄取微弱的区域。鉴于骨扫描显示疾病为寡转移性质且患者年轻,他适合接受转移灶导向治疗。进行了单光子发射计算机断层扫描(SPECT)/CT以进一步明确该病变特征。结果显示其为脂肪骨髓密度内的一个小软组织密度病变,提示骨髓受累。在获取先进检查手段受限的高危前列腺癌患者中,可能需要对这类放射性示踪剂摄取微弱的区域进行更敏感的评估。随着技术进步其检出率提高,它们的意义也需要重新评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9d1/10010852/5972ca54f562/10-1055-s-0042-1757281-i2220005-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9d1/10010852/5972ca54f562/10-1055-s-0042-1757281-i2220005-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9d1/10010852/5972ca54f562/10-1055-s-0042-1757281-i2220005-1.jpg

相似文献

1
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?寡转移性前列腺腺癌患者中,是否需要对MDP摄取微弱的区域进行进一步评估?
World J Nucl Med. 2022 Oct 28;22(1):40-42. doi: 10.1055/s-0042-1757281. eCollection 2023 Mar.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Head-to-head comparison of Tc-PSMA and Tc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial.Tc-PSMA 与 Tc-MDP SPECT/CT 对头对头比较诊断前列腺癌骨转移:一项前瞻性、对比成像试验。
Sci Rep. 2022 Sep 26;12(1):15993. doi: 10.1038/s41598-022-20280-x.
4
Intra-individual comparison of F-sodium fluoride PET-CT and Tc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.个体内比较 F-氟化钠 PET-CT 和 Tc 骨闪烁扫描 SPECT 在前列腺癌或乳腺癌高危患者骨骼转移(MITNEC-A1):一项多中心、3 期试验。
Lancet Oncol. 2022 Dec;23(12):1499-1507. doi: 10.1016/S1470-2045(22)00642-8. Epub 2022 Nov 4.
5
The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.高危前列腺癌患者骨转移的检测:99mTc-MDP平面骨闪烁显像、单视野和多视野SPECT、18F-氟化物PET以及18F-氟化物PET/CT。
J Nucl Med. 2006 Feb;47(2):287-97.
6
Intraindividual Comparison of Tc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand Tc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer.Tc-亚甲基二膦酸盐与前列腺特异性膜抗原配体 Tc-MIP-1427 用于骨转移前列腺癌患者的个体内比较。
J Nucl Med. 2018 Sep;59(9):1373-1379. doi: 10.2967/jnumed.117.200220. Epub 2018 Jan 25.
7
Prostatic bed calcification with [99mTc]Tc-MDP uptake: Easy to miss on planar images.前列腺床钙化伴[99mTc]锝-亚甲基二膦酸盐摄取:在平面图像上容易漏诊。
Nucl Med Rev Cent East Eur. 2023;26(0):42-43. doi: 10.5603/NMR.a2022.0045. Epub 2022 Dec 30.
8
Tc-MDP uptake in SPECT/CT by a bladder hernia simulating inguinal metastasis: A case report.膀胱疝在SPECT/CT上模拟腹股沟转移灶的Tc-MDP摄取:一例报告
Oncol Lett. 2016 Feb;11(2):1398-1400. doi: 10.3892/ol.2016.4091. Epub 2016 Jan 8.
9
(18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描及99m锝-亚甲基二膦酸盐骨闪烁显像在1例厄尔海姆-切斯特病中的应用
Hell J Nucl Med. 2011 Sep-Dec;14(3):311-2.
10
Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.非小细胞肺癌患者的不一致发现:骨扫描完全正常与正电子发射断层扫描/计算机断层扫描显示广泛骨转移。
Eur J Cardiothorac Surg. 2010 Apr;37(4):792-6. doi: 10.1016/j.ejcts.2009.11.011. Epub 2009 Dec 16.

本文引用的文献

1
Management of Oligometastatic Prostate Cancer.寡转移前列腺癌的管理
Appl Radiat Oncol. 2020 Sep;9(3):6-10. Epub 2020 Sep 9.
2
Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?在高危前列腺癌患者的初始分期中,添加骨骼成像到 68-Ga-前列腺特异性膜抗原-PET/CT 是否有用?
Nucl Med Commun. 2020 Nov;41(11):1183-1188. doi: 10.1097/MNM.0000000000001268.
3
Methylene Diphosphonate Bone Scan Scintigraphic Image Enhancement using Gamma Correction and Optimizing the Value of Gamma.
使用伽马校正和优化伽马值的亚甲基二膦酸盐骨扫描闪烁图像增强
Indian J Nucl Med. 2020 Jan-Mar;35(1):21-27. doi: 10.4103/ijnm.IJNM_128_19. Epub 2019 Dec 31.
4
Epidemiology of Prostate Cancer.前列腺癌流行病学
World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20.
5
Ga-PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?镓-PSMA PET/CT 取代骨扫描在前列腺癌骨转移初始分期中的应用:已成定局?
Clin Genitourin Cancer. 2018 Oct;16(5):392-401. doi: 10.1016/j.clgc.2018.07.009. Epub 2018 Jul 21.
6
Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review.基于前列腺特异性膜抗原(PSMA)的正电子发射断层扫描(PET)用于高危前列腺癌的初始分期:一项系统评价。
World J Urol. 2018 Apr;36(4):519-527. doi: 10.1007/s00345-018-2182-1. Epub 2018 Jan 17.
7
Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.寡转移前列腺癌:定义、临床结局和治疗考虑因素。
Nat Rev Urol. 2017 Jan;14(1):15-25. doi: 10.1038/nrurol.2016.175. Epub 2016 Oct 11.